search
Back to results

Effectiveness of Anal Enlargement by Dilators as a Therapeutic Physical Tool in Acute Anal Fissure

Primary Purpose

Acute Anal Fissure

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Anal dilators
lateral internal sphincterotomy
Sponsored by
Sheba Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Acute Anal Fissure focused on measuring Anal fissure, anal dilator, anal pain, physiotherapy

Eligibility Criteria

18 Years - 85 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • age 18-85 years
  • Must have anal pain during bowel movements
  • Must have acute posterior anal fissure
  • Must have candidacy for surgery after failure of conservative treatment, or recurrence of the problem.

Exclusion Criteria:

  • Concomitant anal pathology (anorectal fistulae,abscesses).
  • Previous surgery on the pelvic floor.
  • Inflammatory bowel disease
  • Inability to sign consent to participate in the study
  • Pregnancy

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm 3

    Arm Type

    Experimental

    No Intervention

    Active Comparator

    Arm Label

    research

    waiting

    surgery

    Arm Description

    The subjects in the study group will undergo a series of 4 treatments by 2 certified physiotherapists for pelvic floor treatment that will include instruction in self-use of anal dilators once a week for four weeks. The anal dilation will be performed using Dilatan® anal dilators (Enterprises Sapimed, Alessandria) in varying sizes of 22, 23 and 27 mm. In the first week, a 20 mm dilator will be inserted twice a day for at least 10 minutes. In the second week, a 23 mm extender will be inserted into the anus, twice a day for at least 10 minutes. In the last two weeks, a 27 mm extender will be inserted twice a day for at least 10 minutes. To facilitate the insertion of the extender, patients will use lubricating cream. At the end of each week, patients will meet with a pelvic floor physiotherapist to make sure that the insertion is done properly, that there are no side effects and that it is possible to move on to the next step.

    The subjects in the waiting group will be able after a month to choose to undergo surgery or also receive treatment by extenders.

    The subjects in the surgery group will undergo surgical treatment only.

    Outcomes

    Primary Outcome Measures

    Full recovery
    The incidence of patients who achieved a full recovery of fissure at the end of treatment period

    Secondary Outcome Measures

    Normal defecation
    The incidence of patients who achieved normal defecation at the end of the treatment period
    Quality of life
    The incidence of patients who achieved higher score of quality of life at the end of the treatment period

    Full Information

    First Posted
    March 24, 2021
    Last Updated
    April 1, 2021
    Sponsor
    Sheba Medical Center
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04828889
    Brief Title
    Effectiveness of Anal Enlargement by Dilators as a Therapeutic Physical Tool in Acute Anal Fissure
    Official Title
    A Prospective Interventional Study to Examine the Effectiveness of Anal Enlargement by Dilators as a Therapeutic Physical Tool in Acute Anal Fissure
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    March 2021
    Overall Recruitment Status
    Unknown status
    Study Start Date
    May 1, 2021 (Anticipated)
    Primary Completion Date
    May 1, 2022 (Anticipated)
    Study Completion Date
    September 1, 2022 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Sheba Medical Center

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The treatment of anal fissure is mainly surgical. There are complications to this treatment, including damage to the inner anal sphincter and the appearance of fecal incontinence. Anal dilators are devices that allow gradual enlargement of the anus. To date, the use of these dilators has been in cases of sphincter scarring after a surgical procedure that has caused emptying difficulties. Only recently has the use of anal dilators been tried as a treatment for acute anal fissure. The study is designated to examine whether healing of the fissure can be achieved by conservative treatment with anal extensions and obviating the need for surgical treatment.
    Detailed Description
    Open prospective study. The study will include 75 patients (men and women) aged 18-85 years who are diagnosed with acute anal fissure and candidates for surgery after conservative treatment failure or recurrence of the problem. During the waiting period for surgery, which lasted about a month, patients will be divided into three equal-sized groups at random (research, waiting and surgery). Before the start of treatment and at the end of the waiting and surgery period, all patients will undergo: Anal examination by a proctologist to assess the presence and location of the the fissure Fill out a clinical questionnaire that examines the sensation of pain, burning, itching and bleeding during defecation Fill in the Psychometric properties of a questionnaire (HEMO-FISSQoL) to assess the effect of the fissure on daily functioning Fill out a pain assessment questionnaire (VAS) Fill out a quality of life questionnaire. Only patients with evidence of acute anal fissure in the physical examination will be included in the study. The subjects in the study group will undergo a series of 4 treatments by 2 certified physiotherapists for pelvic floor treatment that will include instruction in self-use of anal dilators once a week for four weeks. The anal dilation will be performed using 'Dilatan'® anal dilators in varying sizes of 22, 23 and 27 mm. In the first week, a 20 mm dilator will be inserted twice a day for at least 10 minutes. In the second week, a 23 mm dilator will be inserted into the anus, twice a day for at least 10 minutes. In the last two weeks, a 27 mm dilator will be inserted twice a day for at least 10 minutes. To facilitate the insertion of the dilator, patients will use lubricating cream. At the end of each week, patients will meet with a pelvic floor physiotherapist to make sure that the insertion is done properly, that there are no side effects and that it is possible to move on to the next step. The subjects in the waiting group will be able after a month to choose to undergo surgery or also receive treatment by dilators. The subjects in the surgery group will undergo surgical treatment only. At the end of the waiting month, a comparison will be made between the indicators of the two groups: research and waiting, in order to evaluate the effectiveness of the treatment in the research group. In the surgery group, these indices will be examined one month after the surgery The indices to be examined are: Disappearance of the fissure by proctologist's examination Disappearance of pain, burning, itching and bleeding during defecation Improving the level of pain by using a VAS subjective assessment scale from 1-10 Improving the effect of the fissure on daily functioning by using the HEMO-FISSQoL Improving the quality of life of the subjects by using the 36-Item Short Form Survey (SF-36)- Quality of Life Questionnaire Further assessments of the improvement in the quality of life of the subjects in the study group will be made three months and 6 months after the end of the experiment.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Acute Anal Fissure
    Keywords
    Anal fissure, anal dilator, anal pain, physiotherapy

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Model Description
    Parallel groups: treatment group( with dilators) versus conservative treatment ( follow up)
    Masking
    None (Open Label)
    Allocation
    Non-Randomized
    Enrollment
    75 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    research
    Arm Type
    Experimental
    Arm Description
    The subjects in the study group will undergo a series of 4 treatments by 2 certified physiotherapists for pelvic floor treatment that will include instruction in self-use of anal dilators once a week for four weeks. The anal dilation will be performed using Dilatan® anal dilators (Enterprises Sapimed, Alessandria) in varying sizes of 22, 23 and 27 mm. In the first week, a 20 mm dilator will be inserted twice a day for at least 10 minutes. In the second week, a 23 mm extender will be inserted into the anus, twice a day for at least 10 minutes. In the last two weeks, a 27 mm extender will be inserted twice a day for at least 10 minutes. To facilitate the insertion of the extender, patients will use lubricating cream. At the end of each week, patients will meet with a pelvic floor physiotherapist to make sure that the insertion is done properly, that there are no side effects and that it is possible to move on to the next step.
    Arm Title
    waiting
    Arm Type
    No Intervention
    Arm Description
    The subjects in the waiting group will be able after a month to choose to undergo surgery or also receive treatment by extenders.
    Arm Title
    surgery
    Arm Type
    Active Comparator
    Arm Description
    The subjects in the surgery group will undergo surgical treatment only.
    Intervention Type
    Device
    Intervention Name(s)
    Anal dilators
    Intervention Description
    Anal sphincter training for relaxation
    Intervention Type
    Procedure
    Intervention Name(s)
    lateral internal sphincterotomy
    Intervention Description
    lateral internal sphincterotomy is a firmly established method for treating anal fissures.
    Primary Outcome Measure Information:
    Title
    Full recovery
    Description
    The incidence of patients who achieved a full recovery of fissure at the end of treatment period
    Time Frame
    4 weeks
    Secondary Outcome Measure Information:
    Title
    Normal defecation
    Description
    The incidence of patients who achieved normal defecation at the end of the treatment period
    Time Frame
    4 weeks
    Title
    Quality of life
    Description
    The incidence of patients who achieved higher score of quality of life at the end of the treatment period
    Time Frame
    4 weeks

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    85 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: age 18-85 years Must have anal pain during bowel movements Must have acute posterior anal fissure Must have candidacy for surgery after failure of conservative treatment, or recurrence of the problem. Exclusion Criteria: Concomitant anal pathology (anorectal fistulae,abscesses). Previous surgery on the pelvic floor. Inflammatory bowel disease Inability to sign consent to participate in the study Pregnancy
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Miri Raveh
    Phone
    0547473724
    Email
    miriavikar@gmail.com
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Dan Carter
    Organizational Affiliation
    Sheba Medical Center
    Official's Role
    Study Director

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Effectiveness of Anal Enlargement by Dilators as a Therapeutic Physical Tool in Acute Anal Fissure

    We'll reach out to this number within 24 hrs